117184-53-9

Usage

Uses

Aranorosin is an inhibitor of anti-apoptotic functions regulated by Bcl-2.

Upstream product

• 152984-48-0 Ethyl (2E,4E,6R)-4,6-dimethyl-2,4-dodecadienoic acid 
• 152899-16-6 Ethyl (2E,4R)-2,4-dimethyl-2-decenoate 
• 179681-13-1 (2E,4R)-2,4-Dimethyl-2-decenal 
• 7786-29-0 (S)-α-methyloctanal 
• 7786-29-0 (R)-α-methyloctanal 
• 120925-50-0 (R)-2-methyloctan-1-ol 
• 4089-07-0 L-tyrosine ethyl ester monohydrochloride 
• 3004-93-1 (R)-(-)-2-methyloctanoic acid 
• 152899-14-4 <3(2'S),4S>-3-(2-Methyl-1-oxooctyl)-4-(phenylmethyl)-2-oxazolidinone 
• 153077-11-3 Ethyl (2S,2'E,4'E,6'S)-2-(4,6-dimethyldodeca-2,4-dienoylamido)-3-(4-hydroxyphenyl)propanoate 
• 153077-12-4 (2E,4E)-(S)-4,6-Dimethyl-dodeca-2,4-dienoic acid [(S)-1-formyl-2-(4-hydroxy-phenyl)-ethyl]-amide 
• 138804-53-2 Ethyl (2E,4E,6S)-4,6-dimethyldodeca-2,4-dienoate 
• 138875-82-8 (2E,4E,6S)-4,6-Dimethyl-2,4-dodecadienoic acid 
• 138804-52-1 Ethyl (2E,4S)-2,4-dimethyl-2-decenoate 

Relevant academic research and scientific papers

The total synthesis of the diepoxycyclohexanone antibiotic aranorosin and novel synthetic analogues

A short synthesis of the novel antibiotic aranorosin in chiral form is described which employs (i) a novel hypervalent iodine-mediated oxidative hydroxylation of a tyrosinal derivative and (ii) a stereocontrolled cis-bisepoxidation in the key steps. A similar procedure was employed to prepare 6′-epiaranorosin, and hence establish the stereochemistry of the natural compound, and to prepare novel aranorosin analogues. An organometallic route is described which gives desamidoaranorosin.

Total synthesis and structure assignment of the antitumor antibiotic aranorosin

The structurally unique antifungal and antitumor antibiotic aranorosin was prepared in a convergent, stereoselective sequence. Oxidative cyclization of N-protected L-tyrosine, followed by face-selective 1,2-addition of [(benzyloxy)methyl]lithium, Henbest oxidation in the presence of Kishi's radical inhibitor, and simultaneous N,O-deprotection led to an amino diol which was N-acylated with the fatty acid side-chain segment. After a low-temperature reduction of the lactone moiety to the lactol, the carbonyl function was regenerated under neutral conditions by diol cleavage with sodium periodate. Preparation of the acid side chain involved a diastereoselective imide α-alkylation directed by Evans' oxazolidinone auxiliary, followed by a series of Wittig-Horner chain extensions. Since the relative configuration at the C(6') position of the natural product had not been determined, we prepared both the (6'S) and the (6'R) isomers of aranorosin. Comparison of synthetic material with the reported spectral data for natural (-)-aranorosin, especially 1H and 13C NMR and [α](D), did not allow a definitive assignment. After purification of a sample of the isolated material from Pseudoarachniotus roseus the corrected [α](D) strongly indicated the (6'R)-stereochemistry for the natural compound. This assignment was confirmed by circular dichroism spectra for (6'S)- and (6'R)-aranorosin and the natural material.

A concise synthesis of the novel antibiotic aranorosin

A short synthesis of the novel antibiotic aranorosin is described which employs a novel hypervalent iodine-mediated oxidative hydroxylation of a tyrosinal derivative in the key step. A similar procedure was employed to prepare 6'-epiaranorosin, and hence establish the stereochemistry of the natural compound.